Company: TVRD
Filing Date: 2025-10-20
Form Type: S-1/A
Source: 0001104659-25-100896
Chunk: 369

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-20
Form: S-1/A
Chunk 369
---
                 | $ | 2,136 | ​ | ​ | ​ | ​                     | $ | 72 | ​ | ​ |

6. Intangible Assets Intangible assets consisted of the following as of June 30, 2025 and December 31, 2024 (in thousands):

| ​                              | ​ | ​ | As ofJune 30,2025 |   |      |   | ​ | ​ | As ofDecember 31,2024 |   |      |   | ​ |
|:-------------------------------|:--|:--|:------------------|:--|-----:|:--|:--|:--|:----------------------|:--|-----:|:--|:--|
| Licensed patent rights         | ​ | ​ | ​                 | $ |  826 | ​ | ​ | ​ | ​                     | $ |  826 | ​ | ​ |
| Less: accumulated amortization | ​ | ​ | ​                 | ​ | -472 | ​ | ​ | ​ | ​                     | ​ | -441 | ​ | ​ |
| Total intangible assets, net   | ​ | ​ | ​                 | $ |  354 | ​ | ​ | ​ | ​                     | $ |  385 | ​ | ​ |

As of June 30, 2025, the expected remaining amortization expense is as follows (in thousands):

| Year Ended December 31,     
 2025 (remaining six months) | ​ 
 ​ | ​ 
 ​ | Amount 
 ​      |   |  32 | ​ | ​ 
 ​ |
|:----------------------------|:--|:--|:-------|:--|----:|:--|:--|
| 2026                        | ​ | ​ | ​      | ​ |  63 | ​ | ​ |
| 2027                        | ​ | ​ | ​      | ​ |  63 | ​ | ​ |
| 2028                        | ​ | ​ | ​      | ​ |  63 | ​ | ​ |
| 2029                        | ​ | ​ | ​      | ​ |  63 | ​ | ​ |
| Thereafter                  | ​ | ​ | ​      | ​ |  70 | ​ | ​ |
| Total                       | ​ | ​ | ​      | $ | 354 | ​ | ​ |

The Company recognized less than $0.1 million for amortization expense for each of the three and six months